Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: A

Yicong Ye1, Ming Yang1, Shuyang Zhang1

  • 1Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.

Plos One
|June 23, 2017
PubMed

Insights

Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) significantly reduces mortality in left main coronary artery disease (LM CAD) patients compared to angiography-guided PCI. This meta-analysis confirms IVUS guidance improves outcomes, lowering risks of death and complications.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Current guidelines suggest intravascular ultrasound (IVUS) guidance for percutaneous coronary intervention (PCI) in left main coronary artery disease (LM CAD).
  • Evidence comparing IVUS-guided versus angiography-guided PCI in LM CAD requires comprehensive synthesis.

Purpose of the Study:

  • To compare the effectiveness of IVUS-guided PCI versus angiography-guided PCI in patients with LM CAD.
  • To evaluate the impact of IVUS guidance on mortality and other adverse events in LM CAD patients.

Main Methods:

  • Systematic literature search of MEDLINE, Embase, and Cochrane Central Register of Controlled Trials.
  • Inclusion of 10 studies (1 randomized, 9 non-randomized) with 6,480 patients comparing IVUS-guided with angiography-guided PCI in LM CAD.
  • Primary outcome assessed was mortality (all-cause and cardiac death).

Main Results:

  • IVUS-guided PCI was associated with significantly lower risks of all-cause death (RR 0.60) and cardiac death (RR 0.47) compared to angiography-guided PCI.
  • Reduced risks observed for target lesion revascularization (RR 0.43) and in-stent thrombosis (RR 0.28) with IVUS guidance.
  • Beneficial effects of IVUS-guided PCI were consistent across study types, populations, and follow-up durations.

Conclusions:

  • IVUS-guided PCI significantly reduces all-cause mortality by approximately 40% in patients with LM CAD compared to conventional angiography guidance.
  • IVUS guidance is associated with improved safety outcomes, including reduced cardiac death, revascularization, and in-stent thrombosis.
  • The findings support the use of IVUS guidance in LM CAD interventions.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
880
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K